Drug intelligence / Profile preview

pachyman

Development stage
Unknown
Lead developer
Johns Hopkins University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Pachyman is a naturally occurring beta-glucan polysaccharide extracted from the sclerotium of the edible medicinal fungus *Poria cocos* (Fuling). Chemically, it consists of a beta-(1→3)-D-glucan backbone with beta-(1→6)-D-glucan branches. Pachyman acts as a ligand for C-type lectin domain family 7 member A (Dectin-1), a pattern-recognition receptor expressed on myeloid cells and certain T-cell subpopulations. Research led by Johns Hopkins University has demonstrated that oral administration of pachyman modulates the gut-immune-brain axis, inhibiting the activation of colonic Dectin-1+ macrophages and gamma-delta 17 T cells. This mechanism has been shown to reverse psychosocial and cognitive deficits, social avoidance, and depressive-like behaviors in preclinical models of chronic social defeat stress and EcoHIV infection.

Other names
1,3-beta-D-glucanbeta-pachymanPoria cocos polysaccharidePoria glucan
02

Targets

CLEC7A (Dectin-1)

Beyond the preview

Go deeper on pachyman.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pachyman.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call